+1 (561) 832 9277 icausa@icausa.org

2017 Fellowships

ICA USA has published the following list of Research Fellowships available for funding in 2018. 

Click this link to download a complete list of the 2018 fellowships available for funding.

For more information or individual fellowship abstracts please call ICA USA at 561-832-9277 or download the 2018 Fellowship Abstracts.

To have us contact you about funding a 2016 Fellowship, complete the Fellowship Inquiry Contact Form here.

Descriptions of 2018 Fellowships:

Lin Medical Center, Prof. Ben-Arie Eran
Reducing anxiety & post-operative pain in patients with gynecological cancer referred to peri & intra-operative acupuncture & integrative medicine: A randomized controlled study.
Funding Requested $22,000.00

Ben-Gurion University of the Negev, Dr. Barak Rotblat
Focused functional interrogation of long noncoding RNA’s associated with poor patient outcome. This study will bring forth lncRNAs as a new promising diagnostic tool and as drug targets in glioblastoma.
Funding Requested $52,000.00

Hadassah Medical Center Ein Kerem Campus, Dr. Menachem Gross
Tracheoesophageal speech with voice prosthesis (VP) is the preferred method for voice restoration following laryngectomy in a patient with laryngeal cancer. Severe infections often follow, A new sustained release application of Chlorhexidine to stop these infections will be studied.
Funding Requested $22,000.00

Schneider Children’s Medical Center, Dr. Orna Steinberg Shemer
Understanding the pathways involved in malignant transformation (Leukemia) development in patients with severe congenital neutropenia, a rare blood disorder characterized by abnormally low levels of certain white blood cells (neutrophils) in the body (neutropenia).
Funding Requested $52,000.00

The Hebrew University of Jerusalem, Dr. Tal Burstein Cohen
Decoding the anti-tumor roles of PROS1 (a protein secreted by immune cells) in the tumor microenvironment. Inhibiting PROS1 arrested cancer progression, revealing its novel anti-tumor role. Here we propose to test whether it may be further developed as an anti-cancer therapy.
Funding Requested $52,000.00

The Hebrew University of Jerusalem, Dr. Zvi Granot
Molecular Characterization of the Inhibitory Effect of TGFbeta on Ant-Tumor Netrophils. The study will highlight specific TGFbeta response pathways that may be targeted therapeutically to enhance neutrophil anti-cancer responses to immunotherapy.
Funding Requested $22,000.00

Tel Aviv Sourasky Medical Center, Dr. Ilan Bruchim
Development of an infra-red spectroscopy system to identify the presence of gynecologic cancers during surgical tumor procedures that will be more accurate than current frozen section tests.
Funding Requested $22,000.00

University of Haifa, Dr. Liza Barki-Harington
The Role of COX-2 (an inflammatory enzyme) in the breakdown of proteins by SKI-1 protease in the spread of Multiple Myeloma.
Funding Requested $22,000.00

The Hebrew University of Jerusalem, Dr. Yoav Shaul
The essential role of GPX8 in regulating metastatic breast cancer cell fate. The principal aim in this proposal is to formulate protocols to understand the role of an enzyme named GPX8 in metastatic formation.
Funding Requested $22,000.00

Rambam Healthcare Campus, Dr.Rostislav Novak
The identification of precise molecular targets in the treatment of Osteosarcoma, a devastating pediatric cancer for which current therapy is of limited value.
Funding Requested $22,000.00

Tel Aviv Sourasky Medical Center, Pro. Zelig Ashhar
Will combining CAR T cells therapy and blockades of inhibitory pathways have a synergistic anti-Multiple Myeloma effect? We expect that a combined treatment can improve CAR T cell-based immunotherapy, may provide effective and durable benefit to MM patients.
Funding Requested $22,000.00

Bar-Ilan University, Dr. Nissan Yissachar
Chemotherapies disrupt the healthy communication between gut bacteria & the immune system. The goal is to find new therapeutic approaches to reduce these side effects, & boost anti-cancer therapy.
Funding Requested $52,000.00

The Hebrew University of Jerusalem, Dr. Yafit Gilboa
Many cancer survivors report cognitive decline impacting their daily lives. We will combine occupational therapy with computerized training in an effort to diminish this decline.
Funding Requested $22,000.00

Hadassah Medical Center, Dr. Iris Lavon
The mechanistic role of Androgen Receptor (AR) Expression in Glioblastoma Multiforme. The objective is to understand the signaling pathway in which AR expression contributes to cancer.
Funding Requested $22,000.00

The Weizmann Institute of Science, Prof Rivka Dikstein
Regulation of stability of mammalian mRNAs by transcription-dependent m6A modification.
Funding Requested $22,000.00

Tel Aviv University, Dr. Tzafrir Zor
Effects of ceramide 1-phosphate (C1P) on macrophages and cancer cells via TLR4.
Funding Requested $22,000.00

Rambam Healthcare Campus, Dr. Lena Ilan
Identifying & disrupting key interactions between the two main cancer regulatory pathways, (motor & glycolysis), limiting cancer cells’ plasticity & ability to use redundant pathways to reach constant activation that enable cell growth and propagation.
Funding Requested $22,000.00

The Academic College Tel Aviv-Yaffo, Dr. Michal Braun
Compassion Fatigue (state of tension & preoccupation with traumatized, suffering patients) & Compassion Satisfaction (positive benefits that helping professionals derive working with traumatized, suffering people) among Israeli oncologists.
Funding Requested $22,000.00

Ben-Gurion University of the Negev, Dr. Dan Levy
Lysine Methylation in Breast Cancer. Work focuses on the protein SETD which preliminary data suggests leads to more aggressive and invasive cancer. Cancer research is shifting to more personalized approaches which require the identification and understanding of the expression of biomarkers that modulate breast cancer.
Funding Requested $22,000.00

For more information on fellowship funding please call our office at (561) 832-9277.